Exhibit 107

 

Calculation of Filing Fee Tables

 

Schedule 14A

(Form Type)

 

Enzo Biochem, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Transaction Valuation

 

   Proposed
Maximum
Aggregate
Value of
Transaction (1)(2)		   Fee rate   Amount of
Filing Fee		 
Fees to Be Paid  $146,000,000(3)   0.00011020   $16,089.20 
Fees Previously Paid  $0        $0 
Total Transaction Valuation  $146,000,000           
Total Fees Due For Filing            $16,089.20 
Total Fees Previously Paid            $0 
Total Fee Offsets            $0 
Net Fee Due            $16,089.20 

 

(1) Title of each class of securities to which transaction applies: N/A

 

(2) The aggregate number of securities to which the asset sale applies: N/A

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

The filing fee was determined by multiplying 0.00011020 by $146,000,000. The purchase price payable under the Asset Purchase Agreement (as defined in the proxy statement) is $146,000,000 to be received by Enzo Biochem, Inc.